Bleed Treatment Outcomes from the XTEND-ed Study in Patients Aged 50 Years and Older
Johannes Oldenburg, Barbara Konkle, Toshko Lissitchkov, Pratima Chowdary, Liane Khoo, Katsuyuki Futatake, Elena Santagostino, Helena Palmborg, Linda Bystrická, Jennifer Dumont, Meredith Foster, Sriya Gunawardena, Andrew Wilson, Annette von Drygalski, Scott Cleland
Session: Posters/Exhibits/Break
- Posters/Exhibits/Break (On-Demand)
|
FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of emicizumab
Johannes Oldenburg, Gary Benson, Pratima Chowdary, Robert Klamroth, Anne Lienhart, Davide Matino, Camila Martins Mazini Tavares, Keiji Nogami, Flora Peyvandi, Amalie Rhode Høgh Nielsen, Guy Young, Emily Waters, Allison P Wheeler, Atish Patel
Session: Posters/Exhibits/Break
- Posters/Exhibits/Break (On-Demand)
|
Mim8 Prophylaxis in Adults and Adolescents with Hemophilia A: 52-Week Efficacy and Safety Outcomes from the Phase 3 FRONTIER2 Study
Steven R Lentz, Aby Abraham, Cihan Ay, Anthony KC Chan, Victor Jiménez-Yuste, Johannes Oldenburg, Maria Elisa Mancuso, Johnny Mahlangu, Tadashi Matsushita, Lize van Vulpen, Renchi Yang, Amalie Rhode Høgh Nielsen, Ilgiz Rakhmatullin, Emily Waters, Pratima Chowdary, Maria Lage
Session: Posters/Exhibits/Break
- Posters/Exhibits/Break (On-Demand)
|
Concizumab Efficacy in Patients With Hemophilia A/B Without Inhibitors from the Phase 3 explorer8 Study: A Post-hoc Sensitivity Analysis for the Intra-patient Comparison of Concizumab With Previous Prophylaxis
Anthony KC Chan, Hermann Eichler, Julien Bovet, Renée Brown Frandsen, Allison P Wheeler, Emily Waters, Pratima Chowdary, Leandra LePorte
Session: Posters/Exhibits/Break
- Posters/Exhibits/Break (On-Demand)
|